Bilateral central serous chorioretinopathy associated with estrogen modulator diindolylmethane

Ophthalmic Surg Lasers Imaging Retina. 2014 Nov-Dec;45(6):589-91. doi: 10.3928/23258160-20141118-16.

Abstract

Central serous chorioretinopathy (CSCR) is an idiopathic disease associated with states of hypercortisolism that causes fluid to collect under the retina resulting in visual impairment. The authors describe an otherwise healthy female patient who presented with headaches and blurry vision after a 2-month history of excessive daily consumption of diindolylmethane (DIM), an over-the-counter estrogen modulator medication used to treat facial acne. Imaging demonstrated asymmetric, bilateral CSCR with active leakage in the left eye. She was instructed to discontinue DIM and reported that visual improvement began 2 weeks after, with resolution to baseline after 8 weeks.

Publication types

  • Case Reports

MeSH terms

  • Acne Vulgaris / drug therapy
  • Adult
  • Central Serous Chorioretinopathy / chemically induced*
  • Central Serous Chorioretinopathy / diagnosis
  • Central Serous Chorioretinopathy / physiopathology
  • Coloring Agents
  • Estrogen Receptor Modulators / adverse effects*
  • Female
  • Fluorescein Angiography
  • Headache / chemically induced
  • Headache / physiopathology
  • Humans
  • Indocyanine Green
  • Indoles / adverse effects*
  • Nonprescription Drugs
  • Tomography, Optical Coherence
  • Vision Disorders / chemically induced
  • Vision Disorders / physiopathology

Substances

  • Coloring Agents
  • Estrogen Receptor Modulators
  • Indoles
  • Nonprescription Drugs
  • Indocyanine Green
  • 3,3'-diindolylmethane

Supplementary concepts

  • Acne, Adult